Bacille Calmette-Guérin injection instead of purified protein derivative injection in an infliximab treated patient.
University Medical Center Lausanne, Fribourg, Switzerlan. jpaegerter@gmail.com.
J P
JP
Aegerter
Internal Medicine Service, Regional Hospital, Nyon, Fribourg, Switzerlan.
L
L
Christin
Gastroenterology, Regional Hospital, Nyon, Fribourg, Switzerlan.
J
J
Guyot
Pulmonary Medicine Private Practice, Fribourg Switzerland.
J-P
JP
Zellweger
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D004348:Drug Labeling; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D007267:Injections; D055985:Latent Tuberculosis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D019300:Medical Errors; D016896:Treatment Outcome
D000995:Antitubercular Agents; D001500:BCG Vaccine; D005765:Gastrointestinal Agents; D000069285:Infliximab